Psilocybin

The use of psilocybin -- the active component of "magic" mushrooms -- is associated with a decreased likelihood of engaging in criminal behavior, according to new research. The findings have been published in the Journal of Psychopharmacology.

Consuming small doses of psilocybin at regular intervals -- a process known as microdosing -- does not appear to improve symptoms of depression or anxiety, according to new research published in the Journal of Psychopharmacology. The placebo-controlled study casts doubt...

Recent findings published in the journal ACS Pharmacology & Translational Science suggest that psilocybin, in conjunction with psychotherapy, reduces suicidal ideation and loss of meaning among patients with life-threatening cancer. These mental health improvements were maintained months to years following treatment. Cancer...

Psilocybin-assisted psychotherapy appears to increase both cognitive and neural flexibility in patients with major depressive disorder, according to new research published in Translational Psychiatry. But the findings suggest that psychedelic-induced increases in neural flexibility do not always result in cognitive...

Scientists have begun to examine whether the psychedelic drug psilocybin, the active component of "magic" mushrooms, can help people who feel insecure in their attachments to others. Their preliminary research, published in ACS Pharmacology & Translational Science, suggests that psilocybin-assisted...

People who use mental health services in Ireland generally have a favorable view of psychedelic research, according to a new study published in the Irish Journal of Medical Science. A little over half of those surveyed said they would be...

A new double-blind, placebo-controlled neuroimaging study sheds light on how psilocybin alters the way in which the brain processes tactile sensations and mental representations of one's body. The findings have been published in Cerebral Cortex. Psilocybin, the active component in...

Yale scientists have found that a single dose of psilocybin given to mice induces a rapid and long-lasting increase in connections between pyramidal neurons in the medial frontal cortex, an area of the brain known to be involved in control...

Low doses of psilocybin and ketamine can heighten food-related motivation and improve attention in poorly-performing male rats, according to new research published in Frontiers in Pharmacology. The new findings shed light on some of the potential benefits of microdosing, which...

Psilocybin, the active compound in magic mushrooms, may be at least as effective as selective serotonin reuptake inhibitors, the leading type of antidepressant medication, according to research published in the New England Journal of Medicine. The phase 2, double-blind, randomized,...